A retrospective study of the use of palliative external beam radiotherapy (EBRT) in nine patients with Erdheim-Chester disease was conducted through the Rare Cancer Network. Patients received EBRT for bone pain, brain infiltration, or retro-orbital involvement. EBRT typically provided short-term palliation, with later recurrence of symptoms in most cases.
- Common Terminology Criteria for Adverse Events
- Erdheim-Chester disease
- Non-Langerhans cell
- external beam radiotherapy
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging